MTOR and hepatocellular carcinoma: On the other hand, the MAPK/ERK pathways demonstrated a general relative up-regulation (Fig. 6B, C), suggesting that the MAPK/mTOR axis might play a dominant role in HBV+ HCC, leading to a cascade of alterations, particularly in fatty acid biosynthesis and lipid metabolism, which has not been previously reported in existing studies.